Prostate Cancer
Recent Abstracts
GU Cancers Symposium 2012 - Empiric antibiotics for an elevated PSA: A randomized, prospective multiinstitutional trial - Session Highlights
February 7, 2012
FDA approves Bayer radium-223 chloride expanded access program
February 7, 2012
Study shows an investigational urine test can predict high-risk prostate cancer in men who choose ‘watchful waiting’
February 7, 2012
Common genetic variants in prostate cancer risk prediction - results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) - Abstract
February 6, 2012
When is elective pelvic lymph node irradiation indicated in definitive radiotherapy for localized prostate cancer? - Abstract
February 6, 2012
Quality of life associated with treatment of castration-resistant prostate cancer: A review of the literature - Abstract
February 6, 2012
Chemoprevention of prostate cancer: An updated view - Abstract
February 6, 2012
Testosterone and prostate - Abstract
February 6, 2012
A "rolling average" multiple adaptive planning method to compensate for target volume changes in image-guided radiotherapy of prostate cancer - Abstract
February 6, 2012
Use of androgen deprivation therapy in prostate cancer: Indications and prevalence - Abstract
February 6, 2012
Hematological changes during androgen deprivation therapy - Abstract
February 6, 2012
Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis - Abstract
February 6, 2012
Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer - Abstract
February 6, 2012
The Epigenetic promise for prostate cancer diagnosis - Abstract
February 6, 2012
MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer - Abstract
February 6, 2012
Study on the autophagy of prostate cancer PC-3 cells induced by oridonin - Abstract
February 6, 2012
GU Cancers Symposium 2012 - Validation of a cell-cycle progression (CCP) gene panel to improve risk stratification in a contemporary prostatectomy cohort - Session Highlights
February 6, 2012
GU Cancers Symposium 2012 - A randomized phase II study of OGX-427 + prednisone vs. prednisone alone in patients with chemotherapy-naïve metastatic castration resistant prostate cancer - Session Highlights
February 6, 2012
Caveolin-1 as a potential high-risk prostate cancer biomarker - Abstract
February 3, 2012
Matrine inhibits proliferation and induces apoptosis of the androgen‑independent prostate cancer cell line PC-3 - Abstract
February 3, 2012
Page 1299 of 1418
Start
Prev
1294
1295
1296
1297
1298
1299
1300
1301
1302
1303
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free